1. Home
  2. AGEN vs QNC Comparison

AGEN vs QNC Comparison

Compare AGEN & QNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

N/A

Current Price

$6.84

Market Cap

335.6M

Sector

Health Care

ML Signal

N/A

Logo Quantum eMotion Corp. Common Shares

QNC

Quantum eMotion Corp. Common Shares

N/A

Current Price

$1.02

Market Cap

366.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AGEN
QNC
Founded
1994
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.6M
366.4M
IPO Year
1999
2026

Fundamental Metrics

Financial Performance
Metric
AGEN
QNC
Price
$6.84
$1.02
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $26.33
N/A
AVG Volume (30 Days)
★ 856.6K
582.4K
Earning Date
11-05-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.00
N/A
EPS
★ 0.96
N/A
Revenue
★ $42,877,086.00
N/A
Revenue This Year
$9.64
$5,145.73
Revenue Next Year
N/A
$505.80
P/E Ratio
$7.35
★ N/A
Revenue Growth
★ 89.95
N/A
52 Week Low
$2.71
$1.01
52 Week High
$10.19
$3.79

Technical Indicators

Market Signals
Indicator
AGEN
QNC
Relative Strength Index (RSI) 45.89 30.98
Support Level $6.66 N/A
Resistance Level $8.64 $2.26
Average True Range (ATR) 0.46 0.10
MACD 0.05 -0.01
Stochastic Oscillator 57.46 4.00

Price Performance

Historical Comparison
AGEN
QNC

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About QNC Quantum eMotion Corp. Common Shares

Quantum eMotion Corp is a technology development company focused on developing and commercializing intellectual property in quantum-based cryptographic and cybersecurity solutions. The company delivers quantum-based security solutions in software and hardware that embed true quantum randomness at the chip level. Its software offerings include Sentry-Q for securing data across networks and applications; eFlux-Q, a cloud-based entropy distribution system for cryptographic systems and key generation; eCrypto-Q, a developer toolkit combining electron-based QRNG and post-quantum cryptography; and eHot-Q, a quantum-safe hot wallet SDK for digital asset protection. Its hardware solution includes eCore-Q, an electron-based QRNG providing high-speed entropy for cryptographic, AI, and IoT systems.

Share on Social Networks: